Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanfen Niu

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Chemico-Biological Interactions|December 21, 2010
3,5,2',4'-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitorYanfen Niu, Huajie Zhu, Jia Liu, et al.
Plos Neglected Tropical Diseases|May 13, 2026
Evolutionary trends of plague research from 2016 to 2025: A bibliometric analysisYanfen Niu, Yihui Zhang, Song Zhou, et al.
European Journal of Pharmacology|August 23, 2020
Mangiferin promotes intestinal elimination of uric acid by modulating intestinal transportersQiurui Li, Hua Lin, Yanfen Niu, et al.
European Journal of Pharmacology|July 27, 2007
Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic ratsYanfen Niu, Weiping Liu, Changfu Tian, et al.
Journal of Pharmacological Sciences|June 24, 2018
Mangiferin alleviates hypertension induced by hyperuricemia via increasing nitric oxide releasesHua Yang, Wenwei Bai, Lihui Gao, et al.
Pharmaceutical Biology|February 27, 2016
Hypouricaemic action of mangiferin results from metabolite norathyriol via inhibiting xanthine oxidase activityYanfen Niu, Jia Liu, Hai-Yang Liu, et al.
Biological & Pharmaceutical Bulletin|August 1, 2015
Mangiferin Inhibits Renal Urate Reabsorption by Modulating Urate Transporters in Experimental HyperuricemiaHua Yang, Lihui Gao, Yanfen Niu, et al.
Biological & Pharmaceutical Bulletin|November 3, 2017
Inhibition of 3,5,2',4'-Tetrahydroxychalcone on Production of Uric Acid in Hypoxanthine-Induced Hyperuricemic MiceYanfen Niu, Yuanfang Zhou, Hua Lin, et al.
Journal of Natural Products|January 12, 2023
Hypouricemic Actions of the Pericarp of Mangosteen <i>in Vitro</i> and <i>in Vivo</i>Yanfen Niu, Qiang Li, Caixia Tu, et al.
European Journal of Pharmacology|April 23, 2019
Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibitionHua Lin, Caixia Tu, Yanfen Niu, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Chemico-Biological Interactions|December 21, 2010
3,5,2',4'-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitorYanfen Niu, Huajie Zhu, Jia Liu, et al.
Plos Neglected Tropical Diseases|May 13, 2026
Evolutionary trends of plague research from 2016 to 2025: A bibliometric analysisYanfen Niu, Yihui Zhang, Song Zhou, et al.
European Journal of Pharmacology|August 23, 2020
Mangiferin promotes intestinal elimination of uric acid by modulating intestinal transportersQiurui Li, Hua Lin, Yanfen Niu, et al.
European Journal of Pharmacology|July 27, 2007
Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic ratsYanfen Niu, Weiping Liu, Changfu Tian, et al.
Journal of Pharmacological Sciences|June 24, 2018
Mangiferin alleviates hypertension induced by hyperuricemia via increasing nitric oxide releasesHua Yang, Wenwei Bai, Lihui Gao, et al.
Pharmaceutical Biology|February 27, 2016
Hypouricaemic action of mangiferin results from metabolite norathyriol via inhibiting xanthine oxidase activityYanfen Niu, Jia Liu, Hai-Yang Liu, et al.
Biological & Pharmaceutical Bulletin|August 1, 2015
Mangiferin Inhibits Renal Urate Reabsorption by Modulating Urate Transporters in Experimental HyperuricemiaHua Yang, Lihui Gao, Yanfen Niu, et al.
Biological & Pharmaceutical Bulletin|November 3, 2017
Inhibition of 3,5,2',4'-Tetrahydroxychalcone on Production of Uric Acid in Hypoxanthine-Induced Hyperuricemic MiceYanfen Niu, Yuanfang Zhou, Hua Lin, et al.
Journal of Natural Products|January 12, 2023
Hypouricemic Actions of the Pericarp of Mangosteen <i>in Vitro</i> and <i>in Vivo</i>Yanfen Niu, Qiang Li, Caixia Tu, et al.
European Journal of Pharmacology|April 23, 2019
Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibitionHua Lin, Caixia Tu, Yanfen Niu, et al.
Pageof 3